ORKA: Agarwal Arjun discloses a sale

By AlphaYouPublished Sep 21, 2026Form 4

Stocks in this disclosure

Reported activity

Agarwal Arjun

Reporting filer

Agarwal Arjun reported Sale in Oruka Therapeutics, Inc.: 533 units of Common Stock, dated 2026-09-21. The full Form 4 contains 1 transaction entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Agarwal Arjun	2026-09-21	S	Sale	533	95.75	14,219	0 days	Filed terms security Title: Common Stock transaction Date: 2026-09-21 transaction Form Type: 4 transaction Code: S equity Swap Involved: 0 id: F1 transaction Shares: 533 transaction Price Per Share: 95.75 transaction Acquired Disposed Code: D shares Owned Following Transaction: 14219 direct Or Indirect Ownership: D

Owner: Agarwal Arjun
Date: 2026-09-21
Code: S
Action: Sale
Quantity: 533
Price: 95.75
Following holdings: 14,219
Reporting delay: 0 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-09-21
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 533
transaction Price Per Share: 95.75
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 14219
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Agarwal Arjun: Senior Vice President, Finance.
The filing reports a Rule 10b5-1 trading plan.
F1: These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.

Prepared automatically from public filing data. Report a correction.